Legionella pneumophilapneumonia possibly due to ustekinumab therapy in a patient with Crohn’s disease-Reference-Cited by-同舟云学术

Legionella pneumophilapneumonia possibly due to ustekinumab therapy in a patient with Crohn’s disease

Published:2017-02-15 Issue:4 Volume:74 Page:209-212
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Borrás-Blasco Joaquín¹,Cortes Xavier²,Fernandez-Martinez Sergio³,Casterá Elvira¹,Antequera Beatriz⁴

Affiliation:

1. Pharmacy Service, Hospital de Sagunto, Sagunto, Spain

2. Gastroenterology Section, Internal Medicine Division, Hospital de Sagunto, Sagunto, Spain

3. Preventive Medicine Unit, Hospital de Sagunto, Sagunto, Spain

4. Internal Medicine Division, Hospital de Sagunto, Sagunto, Spain

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/74/4/209/28336913/ajhp0209.pdf

Reference17 articles.

1. Janssen-Ortho Inc. Stelara (ustekinumab) prescribing information. www.janssen.com/canada/sites/www_janssen_com_canada/files/product/pdf/ste03092015cpm_nc.pdf (accessed 2016 Jan 31).

2. Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn’s disease—the McGill experience;Kopylov;J Crohns Colitis,2014

3. Ustekinumab: targeting the IL-17 pathway to improve outcomes in psoriatic arthritis;Weitz;Expert Opin Biol Ther,2014

4. Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis;Uhlenhake;Expert Opin Biol Ther,2010

5. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis.];Amy de la Bretèque;Ann Dermatol Venereol,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffuse alveolar hemorrhage associated with ustekinumab treatment;American Journal of Health-System Pharmacy;2021-04-04

2. ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2021-03-17

3. Drug-induced Lung Disease Associated With Ustekinumab in a Pediatric Patient With Crohn Disease;Journal of Pediatric Gastroenterology & Nutrition;2020-05-12

4. Ustekinumab;Reactions Weekly;2017-04